AMA Delegates Adopt Policies on Prescription Drug Monitoring and Meaningful Use | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

AMA Delegates Adopt Policies on Prescription Drug Monitoring and Meaningful Use

November 18, 2015
by Heather Landi
| Reprints

The American Medical Association’s (AMA) policy-making House of Delegates at its interim meeting yesterday adopted a number of health IT-related policies, including a policy aimed at streamlining meaningful use requirements.

Recently, AMA and 110 other medical associations have urged Congressional leaders to intervene with Stage 3 of the meaningful use program. As previously reported in Healthcare Informatics, the AMA, in a letter to members of the Senate and the House, stated that unless lawmakers intervene in the federal electronic health record (EHR) meaningful use program, physicians—who are frustrated by the “near impossibility of compliance with meaningless and ill-informed bureaucratic requirements”—likely will abandon the program completely. The letters point out that “CMS has continued to layer requirement on top of requirement, usually without any real understanding of the way healthcare is delivered at the exam room level.”

The policy adopted by the AMA House of Delegates seeks revisions to quality standards and MU requirements to make them more streamlined, usable and less burdensome. In a release, the AMA stated that it had adopted a policy aimed at accelerating the development and adoption of “universal and enforceable EHR interoperability standards” for all vendors before the implementation of the Medicare Incentive Based Payment (MIPs). 

“The AMA wants the Meaningful Use program to succeed, but swift Congressional action is needed to refocus the goals of the program on promoting better coordinated and high-quality patient care instead of burdensome, administrative tasks for physicians,” AMA Immediate Past Chair Barbara McAneny, M.D., said in a statement.

According to the group’s AMA Wire news source, the new policy also states that AMA will submit a report to the Department of Health and Human Services (HHS), the ONC and CMS concerning shortcomings in EHR interoperability, placing special emphasis on requiring vendors to provide systems that comply with interoperability standards as a basic requirement for certification. The AMA also will take a stance that hospitals and health systems be prevented from requiring specific brands of EHRs for affiliated but independent physicians and will also advocate that sponsoring institutions providing EHRs to physician practices provide data access to physicians if they withdraw support of EHR sponsorship.

AMA, the nation’s largest physician association, also encouraged its members to use its BreaktheRedTape.org site to send messages to Congressional members expressing that Stage 3, now a final rule in public-comment period, creates a costly burden and limits innovation.

Addressing the nation’s opioid epidemic, the AMA delegates also adopted a separate policy statement in support of developing model state legislation that will help increase physician registration and use of state-based prescription drug monitoring programs (PDMP).

According to the AMA release, the policy adopted yesterday calls on the federal government to delay its meaningful use program” until real-time integration between EHRs and PDMPs is achieved and electronic prescribing of schedule II and III drugs is available for the country’s MU certified EHRs.”

“The AMA is committed to continuing its work with the administration and Congress as well as state leaders on efforts that will modernize and fully fund PDMPs,” AMA board member Patrice Harris, M.D., said. “As part of our ongoing work with the Task Force to Reduce Opioid Abuse, we will continue to work together with physicians and health care professionals on efforts to help bring an end to our country’s opioid crisis.”

Get the latest information on Meaningful Use and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Survey: 75 Percent of CIOs Concerned About Incomplete, Inaccurate Medication Data

Despite multidisciplinary efforts to improve medication reconciliation, hospital CIOs still report unsatisfactory results, with three out of four concerned that their organization’s medication history data is incomplete or inaccurate, according to a new survey conducted by the CHIME Foundation.

Michigan Plans to Link State PDMP with Provider EHRs

The State of Michigan is directly adding the Michigan Automated Prescription System (MAPS) into the electronic health records (EHRs) and pharmacy management systems of hospitals, physician groups and pharmacies across the state.

Teladoc to Acquire Medical Consultation Company in $440M Deal

Telehealth company Teladoc has announced that it has acquired medical consultation firm Best Doctors for a deal totaling $440 million in cash and stock.

Study: Digital Health Coaching App Improves Weight Loss, Blood Pressure Management

A digital health app and 1-to-1 coaching platform can help patients lose weight and reduce blood pressure, according to a new study published in the June issue of the Journal of Medical Internet Research.

Rush University Launches Telemedicine Program for Movement Disorders Patients

Chicago-based Rush University Medical Center has launched a new telemedicine program for movement disorders patients.

MGMA Poll: Providers Not Yet Using Data from Patients’ Wearables

Just 6 percent of healthcare professional respondents indicated that their practices were currently using data from patients’ wearables, while 81 percent responded they were not doing so, according to a new survey from the Medical Group Management Association (MGMA).